Thromboemboliske tilfælde ses ofte hos kvinder med avanceret brystcancer og er observeret i kliniske forsøg med Faslodex (se pkt.
Thromboembolic events are commonly observed in women with advanced breast cancer and have been observed in clinical trials with Faslodex (see section 4.8).